191 related articles for article (PubMed ID: 32934136)
1. National Sjögren's Foundation Survey: Burden of Oral and Systemic Involvement on Quality of Life.
McCoy SS; Bartels CM; Saldanha IJ; Bunya VY; Akpek EK; Makara MA; Baer AN
J Rheumatol; 2021 Jul; 48(7):1029-1036. PubMed ID: 32934136
[TBL] [Abstract][Full Text] [Related]
2. Significance and Implications of Patient-reported Xerostomia in Sjögren's Syndrome: Findings From the National Institutes of Health Cohort.
Billings M; Dye BA; Iafolla T; Baer AN; Grisius M; Alevizos I
EBioMedicine; 2016 Oct; 12():270-279. PubMed ID: 27639822
[TBL] [Abstract][Full Text] [Related]
3. Oral health status, related behaviours and perceived stress in xerostomia, Sicca and Sjögren's syndromes patients - a cross-sectional study.
Stankeviciene I; Stangvaltaite-Mouhat L; Aleksejuniene J; Mieliauskaite D; Talijuniene I; Butrimiene I; Bendinskaite R; Puriene A
BMC Oral Health; 2024 Apr; 24(1):454. PubMed ID: 38622697
[TBL] [Abstract][Full Text] [Related]
4. The experience of dry mouth and screening for Sjogren's syndrome by the dentist: patient-reported experiences.
Rihab B; Lina EH; Noémie ST; Jean S; Marjolaine G
BMC Oral Health; 2023 Dec; 23(1):1010. PubMed ID: 38102574
[TBL] [Abstract][Full Text] [Related]
5. Peripheral nervous system involvement in Sjogren's syndrome and its impact on quality of life.
S B; Naidu G; Sharma A; Minz RW; Gupta A; Baishya J
Clin Exp Med; 2023 Jun; 23(2):539-545. PubMed ID: 35666344
[TBL] [Abstract][Full Text] [Related]
6. Oral manifestations in patients with Sjögren's syndrome.
Soto-Rojas AE; Villa AR; Sifuentes-Osornio J; Alarcón-Segovia D; Kraus A
J Rheumatol; 1998 May; 25(5):906-10. PubMed ID: 9598889
[TBL] [Abstract][Full Text] [Related]
7. Common Oral Conditions: A Review.
Stoopler ET; Villa A; Bindakhil M; Díaz DLO; Sollecito TP
JAMA; 2024 Mar; 331(12):1045-1054. PubMed ID: 38530258
[TBL] [Abstract][Full Text] [Related]
8. Beyond dry eye: The greater extent of Sjögren's systemic disease symptoms, the impact of COVID-19 and perceptions towards telemedicine identified through a patient co-designed study.
Greenan E; Tynan G; Collins D; Murphy CC; Flood M; Ní Gabhann-Dromgoole J
Health Expect; 2023 Dec; 26(6):2252-2263. PubMed ID: 37470291
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive overview of living with Sjögren's: results of a National Sjögren's Foundation survey.
McCoy SS; Woodham M; Bunya VY; Saldanha IJ; Akpek EK; Makara MA; Baer AN
Clin Rheumatol; 2022 Jul; 41(7):2071-2078. PubMed ID: 35257256
[TBL] [Abstract][Full Text] [Related]
10. Comparison of periodontal indices, DMFT, xerostomia, hyposalivation and oral health-related quality of life in Sjögren's syndrome patients versus healthy individuals: A case-control study.
Molania T; Salehi M; Ehsani H; Moosazadeh M; Niksolat F; Rezaei A; Salehabadi N; Rezaei F; Ebrahimi Saravi M
Dent Med Probl; 2023; 60(1):99-107. PubMed ID: 37023337
[TBL] [Abstract][Full Text] [Related]
11. Elucidating the role of hyposalivation and autoimmunity in oral candidiasis.
Billings M; Dye BA; Iafolla T; Grisius M; Alevizos I
Oral Dis; 2017 Apr; 23(3):387-394. PubMed ID: 27998016
[TBL] [Abstract][Full Text] [Related]
12. Salivary dysfunction and quality of life in Sjögren syndrome: a critical oral-systemic connection.
Stewart CM; Berg KM; Cha S; Reeves WH
J Am Dent Assoc; 2008 Mar; 139(3):291-9; quiz 358-9. PubMed ID: 18310733
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of ultrasound scoring in relation to clinical and histological parameters in xerostomia patients.
Jazzar A; Manoharan A; Brown JE; Shirlaw PJ; Carpenter GH; Challacombe SJ; Proctor GB
Oral Dis; 2019 Jan; 25(1):150-157. PubMed ID: 30120806
[TBL] [Abstract][Full Text] [Related]
14. Salivary scintigraphy for Sjögren's syndrome in patients with xerostomia: A retrospective study.
Nadal M; Levy M; Bakhsh A; Joly A; Maruani A; Vaillant L; Erra B; Samimi M
Oral Dis; 2018 May; 24(4):552-560. PubMed ID: 29117464
[TBL] [Abstract][Full Text] [Related]
15. Oral Nodular Lesions in Patients with Sjögren's Syndrome: Unusual Oral Implications of a Systemic Disorder.
Pinheiro JB; Tirapelli C; Silva CHLD; Komesu MC; Petean FC; Louzada Junior P; León JE; Motta ACF
Braz Dent J; 2017; 28(3):405-412. PubMed ID: 29297564
[TBL] [Abstract][Full Text] [Related]
16. Sjögren's Syndrome: Oral Manifestations and Treatment, a Dental Perspective.
Cartee DL; Maker S; Dalonges D; Manski MC
J Dent Hyg; 2015 Dec; 89(6):365-71. PubMed ID: 26684993
[TBL] [Abstract][Full Text] [Related]
17. Detection of xerostomia, Sicca, and Sjogren's syndromes in a national sample of adults.
Stankeviciene I; Puriene A; Mieliauskaite D; Stangvaltaite-Mouhat L; Aleksejuniene J
BMC Oral Health; 2021 Oct; 21(1):552. PubMed ID: 34706704
[TBL] [Abstract][Full Text] [Related]
18. Oral candidiasis and Sjögren's syndrome.
Soto-Rojas AE; Villa AR; Sifuentes-Osornio J; Alarcón-Segovia D; Kraus A
J Rheumatol; 1998 May; 25(5):911-5. PubMed ID: 9598890
[TBL] [Abstract][Full Text] [Related]
19. Oral manifestations and their treatment in Sjögren's syndrome.
González S; Sung H; Sepúlveda D; González M; Molina C
Oral Dis; 2014 Mar; 20(2):153-61. PubMed ID: 23557026
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and risk factors of neurological involvement in Sjögren's syndrome.
Ye W; Chen S; Huang X; Qin W; Zhang T; Zhu X; Zhu X; Lin C; Wang X
BMC Neurosci; 2018 Apr; 19(1):26. PubMed ID: 29703151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
